Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1488 of 5804
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThe objective of this early feasibility clinical study is to evaluate the safety and effectiveness of several different GORE Glaucoma Drainage Implant configurations in subjects with primary open-angle glaucoma that is uncontrolled by hypotensive medications or for which conventi…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New oil could boost liver cancer treatment
Disease control TerminatedThe phase I/II, double-blind, randomized study will investigate the efficacy and safety of TACE/TAE treatment with T-ACE Oil in patients with unresectable hepatocellular carcinoma.
Phase: PHASE1, PHASE2 • Sponsor: T-ACE Medical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can the HPV vaccine stop the virus in its tracks? new study aims to find out
Disease control Recruiting nowThis is a non-randomized, open label study to assess the reduction of Human Papillomavirus (HPV) infectivity and transmission in women positive for HPV16 and/or 18 in a cervical, oral and anal sample and vaccinated with 9vHPV/Gardasil-9™. The primary objective of the study is to…
Phase: PHASE4 • Sponsor: Miquel Angel Pavon Ribas • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Glass dressing aims to heal diabetic foot ulcers faster
Disease control CompletedThis study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on 2 commercially available treatments for diabetic foot wounds.
Phase: NA • Sponsor: ETS Wound Care, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug aims to ease social struggles in autism
Symptom relief CompletedML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of soci…
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New app aims to help smokers kick the habit for good
Symptom relief CompletedOver 470,000 tobacco users have been served by the Oklahoma Tobacco Helpline (OTH). The OTH reaches a substantial number of smokers each year, but follow-up rates are notoriously low and many smokers may prefer smartphone-based smoking cessation interventions rather than web- or …
Phase: NA • Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New adaptive radiotherapy aims to shrink treatment margins for uterine cancers
Disease control CompletedOnline adaptive radiotherapy has demonstrated to be feasible to reduce inter-fractional radiotherapy errors as it re-optimizes treatment plan every fraction. To investigate the extent and value of margin reduction,we conduct a prospective clinical trial to determine the optimal m…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug R289 offers hope for blood disorder patients who failed other therapies
Disease control Recruiting nowPhase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)
Phase: PHASE1, PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a smaller dose of monkeypox vaccine work just as well?
⭐️ VACCINE ⭐️ CompletedThis study is a Phase 2 randomized, open-label, non-placebo controlled, multi-site clinical trial that will evaluate two intradermal (ID) regimens for Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine compared to the standard subcutaneous (SC) regimen in healthy, vaccinia…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:08 UTC
-
Diabetes drug metformin tested to prevent lung cancer in overweight former smokers
Prevention OngoingThis phase II trial determines the effect of metformin extended release on the risk for developing lung cancer in overweight/obese patients that are at high-risk for developing lung cancer. Metformin is widely used to treat type II diabetes and has a long history of safety and mi…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Donor immune cells get a boost in new cancer trial
Disease control TerminatedOne of the ways that cancer grows and spreads is by avoiding the immune system.NK cells are immune cells that kill cancer cells, but are often malfunctioning in people with colorectal cancer and blood cancers. A safe way to give people with colorectal cancer and blood cancers fre…
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Can a talking therapy tame tics? new study recruits 200 kids
Symptom relief Recruiting nowThe purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can a simple test strip save lives? ohio study aims to find out
Knowledge-focused OngoingThe purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
Phase: NA • Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Steroid cocktail may offer better pain control after knee replacement
Symptom relief Recruiting nowThe objective of this phase 2 study is to investigate the efficacy of Dexamethasone sodium phosphate (DEX) plus Methylprednisolone acetate (MPA) in combination with plain bupivacaine (B) compared with Liposomal Bupivacaine (LB) in combination with plain bupivacaine on post-surgic…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for kids with psoriasis: cosentyx® shows promise in chinese study
Disease control CompletedThis was a non-interventional, prospective, multi-center real world setting study, aiming to provide safety and effectiveness data in Chinese pediatric patients with moderate to severe plaque psoriasis treated with Cosentyx® for up to 52 weeks.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a single dose ease fragile x? new trial tests three drugs
Symptom relief OngoingThe aim of this study is to utilize neurophysiologic assessments, behavioral measures and clinical measures to assess how much deficits associated with Fragile X Syndrome from pre-dose to post-dose using pharmacology.
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Acupuncture may ease Chemo's nerve pain, new study finds
Symptom relief CompletedThis research is being done to determine whether acupuncture can help prevent or lessen chemotherapy-induced peripheral neuropathy (CIPN), a side effect of some kinds of chemotherapy that causes pain, numbness, tingling, swelling, or muscle weakness mostly in the hands or feet. …
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
3D-Guided heat therapy targets enlarged prostate without cutting
Symptom relief CompletedThis is a pilot study on applying 3D-Ultrasound-Guided Transperineal Microwave needle ablation for men with symptomatic benign prostatic hyperplasia (BPH).
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Canadian study monitors Venetoclax's Real-World impact on AML
Disease control OngoingAcute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow and is the most common acute leukemia in adults. This study will evaluate how well venetoclax works to treat AML in adult participants who are ineligible for intensive induction chemotherapy in Canada. Venetoc…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail may tame deadly transplant complication
Disease control OngoingThis is a single arm, open label, phase II clinical trial. Adult patients with hematological malignancies undergoing allogeneic HSCT from first- or second-degree haploidentical donor are eligible for the study if they meet the standard criteria defined in our institutional standa…
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC